Clinical trial
Characteristics and Prognosis of Jejunoileal Gastrointestinal Stromal Tumors (GISTs) in the Era of Imatinib. A Comparative Retrospective Study With Gastric GISTs.
NCT03923400 is registered in ClinicalTrials.gov with Hospital Universitario Virgen de la Arrixaca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Characteristics and Prognosis of Jejunoileal Gastrointestinal Stromal Tumors (GISTs) in the Era of Imatinib. A Comparative Retrospective Study With Gastric GISTs.
- Lead sponsor
- Hospital Universitario Virgen de la Arrixaca
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 1, 2016
- Completion date
- January 31, 2017
- Enrollment
- 77 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
disease-free survival, overall survival, recurrence